She explains how modern activities like social media, video games, and pornography can hijack this reward system, leading to addictive behaviors
A 1mg vial contains 1000mcg, yielding 10 weeks of protocol duration
Likewise, someone with nutritional deficiencies, thyroid dysfunction, PCOS, chronic stress, or inflammatory scalp conditions may require an entirely different approach
Full Disclaimer HERE
Strict control of buffer conditions (pH 7.4) is essential due to the pH sensitivity of the fluorescein probe
Head-to-Head Comparison: Key Metrics Semaglutide: MW 4113.58 Da | Selective GLP-1 RA | Injectable (weekly) or oral (daily with SNAC) | Mean weight loss 14.9% (STEP 1) | FDA-approved 2021 (obesity) Tirzepatide: MW ~4813.45 Da | Dual GLP-1/GIP | Injectable (weekly) | Mean weight loss 22.5% (SURMOUNT-1) | FDA-approved 2023 (obesity) Retatrutide: MW ~4500 Da | Triple GLP-1/GIP/Glucagon | Injectable (weekly) | Mean weight loss 28.7% (TRIUMPH-4 Phase 3) | Phase 3 as of 2026 Orforglipron: MW 541.65 Da | Selective GLP-1 (non-peptide) | Oral (daily, no food restriction) | Mean weight loss ~14.7% (Phase 3) | FDA-approved April 2026 Receptor Selectivity and Mechanism Differences The four compounds represent a spectrum from single-target to multi-target pharmacology
